EP News Bureau

The facility is located at Jadcherla in Telangana

The patents are valid through 2034 and 2026 respectively

First samples to be supplied in July 2018, facility expected to create about 500 jobs by the end of 2018

The conference is being conducted by CDSCO and NDRA of India in collaboration with Ministry of Health & Family Welfare

Appoints Marcus Bergler as its Vice President Global Sales

According to an order, the recommendations of this committee shall be considered by the NPPA which shall pass a reasoned order…

Spread awareness on dementia

Express Pharma (May 15-31, 2017) EXPANDING ACCESS Express Pharma has always taken a keen interest in India’s progress in the…

Deal value decreases to $7.1 billion when compared five months average of $10.6 billion

Increased market diversification is expected due to patent expiries for major insulin products